Free Trial
OTCMKTS:SNYNF

Sanofi (SNYNF) Stock Price, News & Analysis

Sanofi logo
$96.81 0.00 (0.00%)
As of 11/13/2026

About Sanofi Stock (OTCMKTS:SNYNF)

Advanced

Key Stats

Today's Range
$96.81
▼
$96.81
50-Day Range
$76.76
▼
$96.81
52-Week Range
$76.76
▼
$106.34
Volume
20,648 shs
Average Volume
24,846 shs
Market Capitalization
N/A
P/E Ratio
31.39
Dividend Yield
2.89%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sanofi is a France-based global healthcare company focused on the research, development, manufacturing and commercialization of pharmaceutical products and vaccines. Its portfolio includes medicines for immunology, rare diseases, neurology, oncology and other specialty-care areas, as well as treatments for common conditions such as diabetes and cardiovascular disease.

The company’s well-known products include Dupixent, an immunology medicine developed with Regeneron; vaccines marketed through its Vaccines division, including influenza and travel vaccines; and established prescription medicines in several therapeutic categories. Sanofi also develops biologic medicines and other innovative therapies for patients with chronic, debilitating or rare conditions.

Sanofi serves patients and healthcare providers in markets around the world through research, manufacturing and commercial operations across North America, Europe, Asia and other international regions. The company was created in its current form through the 2004 merger of Sanofi-Synthélabo and Aventis, combining the businesses of two major French pharmaceutical groups. Its global headquarters are in Paris, France, and Paul Hudson has served as chief executive officer since 2019.

AI Generated. May Contain Errors.

Sanofi Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

SNYNF MarketRank™: 
0.09480243967 of 5 stars

Sanofi scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Sanofi.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sanofi is 31.39, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.18.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sanofi is 31.39, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.41.

  • Read more about Sanofi's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Sanofi has a short interest ratio ("days to cover") of 46.57, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Sanofi has recently increased by 103.29%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Sanofi is a leading dividend payer. It pays a dividend yield of 4.13%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Sanofi does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Sanofi is 90.78%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Sanofi's dividend.
  • News Sentiment

    Sanofi has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Sanofi this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Sanofi insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    30.06% of the stock of Sanofi is held by institutions.

  • Read more about Sanofi's insider trading history.
Receive SNYNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNYNF Stock News Headlines

Bernstein Sticks to Their Buy Rating for Sanofi (SNYNF)
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
biotech daily dose
J.P. Morgan Sticks to Their Hold Rating for Sanofi (SNYNF)
See More Headlines

SNYNF Stock Analysis - Frequently Asked Questions

Sanofi's stock was trading at $97.2950 on January 1st, 2026. Since then, SNYNF shares have decreased by 0.5% and is now trading at $96.81.

Shares of SNYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/16/2026
Next Earnings (Estimated)
1/28/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:SNYNF
CIK
1121404
Fax
N/A
Employees
76,493
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
31.39
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:SNYNF) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners